← Back to Treatments
🏅 FDA Orphan Designation

Macrelin

macimorelin acetate

Manufacturer: Aeterna Zentaris GmbH

Indicated for:
Isolated growth hormone deficiency type IIIOrphanNon-acquired isolated growth hormone deficiency

FDA-Approved Indications (2)

For the diagnosis of adult growth hormone deficiency

MACRILEN is indicated for the diagnosis of adult growth hormone deficiency (AGHD)

Population: adults

Indications & Usage

1 INDICATIONS AND USAGE MACRILEN is indicated for the diagnosis of adult growth hormone deficiency (AGHD). MACRILEN is a growth hormone (GH) secretagogue receptor agonist indicated for the diagnosis of adult growth hormone deficiency ( 1 ). Limitations of Use : The safety and diagnostic performance has not been established for subjects with BMI > 40kg/m 2 ( 1 ). Limitations of Use The safety and diagnostic performance of MACRILEN have not been established for subjects with a body mass index (BMI) > 40 kg/m 2 .

💙 Support Programs

View all →
Macrelin
Aeterna Zentaris GmbH
Macrelin
Aeterna Zentaris GmbH

Where shown, WAC (Wholesale Acquisition Cost) is an estimate only — your actual cost depends on your insurance plan. Always verify pricing with your pharmacy or insurer.

Medical disclaimer: This information is for educational purposes only. Always consult a qualified healthcare provider before making treatment decisions. Data sourced from FDA and current as of our last update.